Skip to main content
Trillium
  • About
    • Company Profile
    • Management Team
    • Board of Directors
    • Scientific Advisory Board
  • Science
    • Overview
    • CD47
  • Pipeline
    • Overview
    • TTI-621
    • TTI-622
  • For Patients
    • Overview
    • TTI-621-01
    • TTI-622-01
  • Investors
  • Contact
    • Contact Information
    • Careers
  • Menu
  • Investors
  • Stock Information
    • Stock Quote & Chart
    • Historical Price Lookup
    • Analyst Coverage
  • Financial Information
    • SEC Filings
    • Financial Reports
  • Corporate Governance
    • Management Team
    • Board of Directors
    • Governance Documents
    • 2020 Annual Meeting
  • Press Releases
  • Events & Presentations
  • Investor Resources
    • Contact Investor Relations
    • FAQs
    • Email Alerts
    • RSS
Normal
Press Release RSS Feed (opens in new window)

Press Releases

Press release year list 2021 2020 2019 2018 2017 2016 2015 2014 2013
No items found for this year

Cambridge Office

100 Cambridgepark Drive, Suite 510
Cambridge, MA 02140
USA
Tel: +1 857.412.7029

Mississauga Office

2488 Dunwin Drive
Mississauga, ON L5L 1J9
Canada
Tel: +1 416.595.0627

INVESTOR RELATIONS

James Parsons
Chief Financial Officer
Tel: +1 416.595.0627 x232
james@trilliumtherapeutics.com

GENERAL

info@trilliumtherapeutics.com




© Copyright - Trillium Therapeutics Inc. | Graphics © Audra Geras | Terms of Use
  • About
  • Science
  • Pipeline
  • For Patients
  • Investors
  • Contact
Powered By Q4 Inc. 5.52.0.6 (opens in new window)